Effects of melatonin on liver injuries and diseases

International Journal of Molecular Sciences

Volumn 18, Issue 4, 2017, Pages

  Zhang, Jiao Jiao ^a   Meng, Xiao ^a   Li, Ya ^a   Zhou, Yue ^a   Xu, Dong Ping ^a   Li, Sha ^b   Li, Hua Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cirrhosis; Effect; Fatty liver; Fibrosis; Hepatitis; Hepatocarcinoma; Liver injuries; Melatonin; Steatosis

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; AFLATOXIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BENZENE; CARBAMAZEPINE; CARBON TETRACHLORIDE; CASPASE 3; CATALASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIAZEPAM; DOXORUBICIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LETROZOLE; LIPID PEROXIDE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; METHOTREXATE; N ACETYLSEROTONIN; OCHRATOXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHENOBARBITAL; SUPEROXIDE DISMUTASE; TOLUENE; UNINDEXED DRUG; XANTHINE OXIDASE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; ENZYME ACTIVITY; EXPERIMENTAL LIVER INJURY; HUMAN; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; POLLUTANT; REVIEW; SIGNAL TRANSDUCTION; TOXIC HEPATITIS; ANIMAL; DRUG EFFECTS; LIVER; LIVER DISEASES; METABOLISM;

ANIMALS; APOPTOSIS; AUTOPHAGY; HUMANS; LIVER; LIVER DISEASES; MELATONIN;

EID: 85016119765     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18040673     Document Type: Review

References (182)

1. Guerra, S.; Mamede, A.C.; Carvalho, M.J.; Laranjo, M.; Tralhao, J.G.; Abrantes, A.M.; Maia, C.J.; Botelho, M.F. Liver diseases: What is known so far about the therapy with human amniotic membrane? Cell Tissue Bank. 2016, 17, 653-663.
2. Tan, D.X.; Manchester, L.C.; Esteban-Zubero, E.; Zhou, Z.; Reiter, R.J. Melatonin as a potent and inducible endogenous antioxidant: Synthesis and metabolism. Molecules 2015, 20, 18886-18906.
3. Subramanian, P.; Mirunalini, S.; Dakshayani, K.B.; Pandi-Perumal, S.R.; Trakht, I.; Cardinali, D.P. Prevention by melatonin of hepatocarcinogenesis in rats injected with N-nitrosodiethylamine. J. Pineal Res. 2007, 43, 305-312.
4. Ren, W.K.; Liu, G.; Chen, S.; Yin, J.; Wang, J.; Tan, B.; Wu, G.Y.; Bazer, F.W.; Peng, Y.Y.; Li, T. et al. Melatonin signaling in T cells: Functions and applications. J. Pineal Res. 2017.
5. Kennaway, D.J. Are the proposed benefits of melatonin-rich foods too hard to swallow? Crit. Rev. Food Sci. Nutr. 2017, 57, 958-962.
6. Smith, M.R.; Lee, C.; Crowley, S.J.; Fogg, L.F.; Eastman, C.I. Morning melatonin has limited benefit as a soporific for daytime sleep after night work. Chronobiol. Int. 2005, 22, 873-888.
7. Sun, H.; Huang, F.F.; Qu, S. Melatonin: A potential intervention for hepatic steatosis. Lipids Health Dis. 2015, 14, 75.
8. Manchester, L.C.; Coto-Montes, A.; Boga, J.A.; Andersen, L.P.H.; Zhou, Z.; Galano, A.; Vriend, J.; Tan, D.X.; Reiter, R.J. Melatonin: An ancient molecule that makes oxygen metabolically tolerable. J. Pineal Res. 2015, 59, 403-419.
9. Bali, I.; Bilir, B.; Emir, S.; Turan, F.; Yilmaz, A.; Gokkus, T.; Aydin, M. The effects of melatonin on liver functions in arsenic-induced liver damage. Turk. J. Surg. 2016, 32, 233-237.
10. Reiter, R.J.; Mayo, J.C.; Tan, D.X.; Sainz, R.M.; Alatorre-Jimenez, M.; Qin, L.L. Melatonin as an antioxidant: Under promises but over delivers. J. Pineal Res. 2016, 61, 253-278.
11. Ohta, Y.; Kongo, M.; Sasaki, E.; Nishida, K.; Ishiguro, I. Therapeutic effect of melatonin on carbon tetrachloride-induced acute liver injury in rats. J. Pineal Res. 2000, 28, 119-126.
12. Noyan, T.; Komuroglu, U.; Bayram, I.; Sekeroglu, M.R. Comparison of the effects of melatonin and pentoxifylline on carbon tetrachloride-induced liver toxicity in mice. Cell Biol. Toxicol. 2006, 22, 381-391.
13. Ohta, Y.; Kongo-Nishimura, M.; Matsura, T.; Yamada, K.; Kitagawa, A.; Kishikawa, T. Melatonin prevents disruption of hepatic reactive oxygen species metabolism in rats treated with carbon tetrachloride. J. Pineal Res. 2004, 36, 10-17.
14. Kus, I.; Ogeturk, M.; Oner, H.; Sahin, S.; Yekeler, H.; Sarsilmaz, M. Protective effects of melatonin against carbon tetrachloride-induced hepatotoxicity in rats: A light microscopic and biochemical study. Cell Biochem. Funct. 2005, 23, 169-174.
15. Zavodnik, L.B.; Zavodnik, I.B.; Lapshina, E.A.; Belonovskaya, E.B.; Martinchik, D.I.; Kravchuk, R.I.; Bryszewska, M.; Reiter, R.J. Protective effects of melatonin against carbon tetrachloride hepatotoxicity in rats. Cell Biochem. Funct. 2005, 23, 353-359.
16. Oner, J.; Kus, I.; Oner, H. Melatonin increases the expression of insulin-like growth factor I in rats with carbon tetrachlorid-induced hepatic damage. J. Anim. Vet. Adv. 2009, 8, 2256-2261.
17. Cheshchevik, V.T.; Lapshina, E.A.; Dremza, I.K.; Zabrodskaya, S.V.; Reiter, R.J.; Prokopchik, N.I.; Zavodnik, I.B. Rat liver mitochondrial damage under acute or chronic carbon tetrachloride-induced intoxication: Protection by melatonin and cranberry flavonoids. Toxicol. Appl. Pharmacol. 2012, 261, 271-279.
18. Maksimchik, Y.Z.; Dremza, I.K.; Lapshina, E.A.; Cheshchevik, V.T.; Sudnikovich, E.Y.; Zabrodskaya, S.V.; Zavodnik, I.B. Rat liver mitochondria impairment under acute carbon tetrachloride-induced intoxication. Effects of melatonin. Biol. Membr. 2010, 27, 262-271.
19. Ebaid, H.; Bashandy, S.A.E.; Alhazza, I.M.; Rady, A.; El-Shehry, S. Folic acid and melatonin ameliorate carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats. Nutr. Metab. 2013, 10, 20.
20. Aranda, M.; Albendea, C.D.; Lostale, F.; Lopez-Pingarron, L.; Fuentes-Broto, L.; Martinez-Ballarin, E.; Reiter, R.J.; Perez-Castejon, M.C.; Garcia, J.J. In vivo hepatic oxidative stress because of carbon tetrachloride toxicity: Protection by melatonin and pinoline. J. Pineal Res. 2010, 49, 78-85.
21. Ogeturk, M.; Kus, I.; Pekmez, H.; Yekeler, H.; Sahin, S.; Sarsilmaz, M. Inhibition of carbon tetrachloride-mediated apoptosis and oxidative stress by melatonin in experimental liver fibrosis. Toxicol. Ind. Health 2008, 24, 201-208.
22. Sharma, S.; Rana, S.V.S. Melatonin improves liver function in benzene-treated rats. Arh. Hig. Rada Toksikol. 2013, 64, 219-227.
23. Sharma, S.; Rana, S.V.S. Melatonin inhibits benzene-induced lipid peroxidation in rat liver. Arh. Hig. Rada Toksikol. 2010, 61, 11-18.
24. Tas, U.; Ogeturk, M.; Meydan, S.; Kus, I.; Kuloglu, T.; Ilhan, N.; Kose, E.; Sarsilmaz, M. Hepatotoxic activity of toluene inhalation and protective role of melatonin. Toxicol. Ind. Health 2011, 27, 465-473.
25. Pi, H.F.; Xu, S.C.; Reiter, R.J.; Guo, P.; Zhang, L.; Li, Y.M.; Li, M.; Cao, Z.W.; Tian, L.; Xie, J. et al. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy 2015, 11, 1037-1051.
26. Kara, H.; Cevik, A.; Konar, V.; Dayangac, A.; Servi, K. Effects of selenium with vitamin E and melatonin on cadmium-induced oxidative damage in rat liver and kidneys. Biol. Trace Elem. Res. 2008, 125, 236-244.
27. El-Sokkary, G.H.; Nafady, A.A.; Shabash, E.H. Melatonin administration ameliorates cadmium-induced oxidative stress and morphological changes in the liver of rat. Ecotox. Environ. Saf. 2010, 73, 456-463.
28. Guo, P.; Pi, H.F.; Xu, S.C.; Zhang, L.; Li, Y.M.; Li, M.; Cao, Z.W.; Tian, L.; Xie, J.; Li, R.Y. et al. Melatonin improves mitochondrial function by promoting MT1/SIRT1/PGC-1 alpha-dependent mitochondrial biogenesis in cadmium-induced hepatotoxicity in vitro. Toxicol. Sci. 2014, 142, 182-195.
29. Cao, Z.W.; Fang, Y.L.; Lu, Y.H.; Tan, D.X.; Du, C.H.; Li, Y.M.; Ma, Q.L.; Yu, J.M.; Chen, M.Y.; Zhou, C. et al. Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J. Pineal Res. 2017.
30. Romero, A.; Ramos, E.; de Los Rios, C.; Egea, J.; del Pino, J.; Reiter, R.J. A review of metal-catalyzed molecular damage: Protection by melatonin. J. Pineal Res. 2014, 56, 343-370.
31. El-Sokkary, G.H.; bdel-Rahman, G.H.; Kamel, E.S. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 2005, 213, 25-33.
32. Hedayati, M.T.; Omran, S.M.; Soleymani, A.; Taghizadeh, M. Aflatoxins in food products in Iran: A review of the literature. Jundishapur J. Microbiol. 2016, 9, e33235.
33. Akinrinmade, F.J.; Akinrinde, A.S.; Amid, A. Changes in serum cytokine levels, hepatic and intestinal morphology in aflatoxin B1-induced injury: Modulatory roles of melatonin and flavonoid-rich fractions from Chromolena odorata. Mycotoxin Res. 2016, 32, 53-60.
34. Meki, A.R.M.A.; Abdel-Ghaffar, S.K.; El-Gibaly, I. Aflatoxin B1 induces apoptosis in rat liver: Protective effect of melatonin. Neuroendocrinol. Lett. 2001, 22, 417-426.
35. Meki, A.R.M.A.; Esmail, E.E.D.F.; Hussein, A.A.; Hassanein, H.M. Caspase-3 and heat shock protein-70 in rat liver treated with aflatoxin B1: Effect of melatonin. Toxicon 2004, 43, 93-100.
36. Malir, F.; Ostry, V.; Pfohl-Leszkowicz, A.; Malir, J.; Toman, J. Ochratoxin A: 50 years of research. Toxins 2016, 8, 191.
37. Meki, A.R.M.A.; Hussein, A.A.A. Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2001, 130, 305-313.
38. Sutken, E.; Aral, E.; Ozdemir, F.; Uslu, S.; Alatas, O.; Colak, O. Protective role of melatonin and coenzyme Q(10) in ochratoxin a toxicity in rat liver and kidney. Int. J. Toxicol. 2007, 26, 81-87.
39. Aydin, G.; Ozcelik, N.; Cicek, E.; Soyoz, M. Histopathologic changes in liver and renal tissues induced by ochratoxin A and melatonin in rats. Hum. Exp. Toxicol. 2003, 22, 383-391.
40. Cullen, J.M.; Faiola, B.; Melich, D.H.; Peterson, R.A.; Jordan, H.L.; Kimbrough, C.L.; Miller, R.T. Acute α-naphthylisothiocyanate-induced liver toxicity in germfree and conventional male rats. Toxicol. Pathol. 2016, 44, 987-997.
41. Ohta, Y.; Kongo, M.; Sasaki, E.; Ishiguro, I.; Harada, N. Protective effect of melatonin against α-naphthylisothiocyanate-induced liver injury in rats. J. Pineal Res. 2000, 29, 15-23.
42. Ohta, Y.; Kongo, M.; Kishikawa, T. Preventive effect of melatonin on the progression of α-naphthylisothiocyanate-induced acute liver injury in rats. J. Pineal Res. 2003, 34, 185-193.
43. Ohta, Y.; Kongo, M.; Kishikawa, T. Effect of melatonin on changes in hepatic antioxidant enzyme activities in rats treated with α-naphthylisothiocyanate. J. Pineal Res. 2001, 31, 370-377.
44. Calvo, J.R.; Reiter, R.J.; Garcia, J.J.; Ortiz, G.G.; Tan, D.X.; Karbownik, M. Characterization of the protective effects of melatonin and related indoles against α-naphthylisothiocyanate-induced liver injury in rats. J. Cell Biochem. 2001, 80, 461-470.
45. Ohta, Y.; Kongo-Nishimura, M.; Imai, Y.; Matsura, T.; Kitagawa, A.; Yamada, K. Alpha-tocopherol protects against α-naphthylisothiocyanate-induced hepatotoxicity in rats less effectively than melatonin. Chem. Biol. Interact. 2006, 161, 115-124.
46. Kurcer, Z.; Oguz, E.; Iraz, M.; Fadillioglu, E.; Baba, F.; Koksal, M.; Olmez, E. Melatonin improves methanol intoxication-induced oxidative liver injury in rats. J. Pineal Res. 2007, 43, 42-49.
47. Chawla, S.L.; Yadav, R.; Shah, D.; Rao, M.V. Protective action of melatonin against fluoride-induced hepatotoxicity in adult female mice. Fluoride 2008, 41, 44-51.
48. Abdel-Wahab, W.M. AlCl3-induced toxicity and oxidative stress in liver of male rats: Protection by melatonin. Life Sci. J. 2012, 9, 1173-1182.
49. Jung, K.H.; Hong, S.W.; Zheng, H.M.; Lee, D.H.; Hong, S.S. Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-κB during prevention of oxidative liver injury in a dimethylnitrosamine model. J. Pineal Res. 2009, 47, 173-183.
50. Bruck, R.; Aeed, H.; Avni, Y.; Shirin, H.; Matas, Z.; Shahmurov, M.; Avinoach, I.; Zozulya, G.; Weizman, N.; Hochman, A. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J. Hepatol. 2004, 40, 86-93.
51. El-Sokkary, G.H.; Cuzzocrea, S.; Reiter, R.J. Effect of chronic nicotine administration on the rat lung and liver: Beneficial role of melatonin. Toxicology 2007, 239, 60-67.
52. Garcia-Rubio, L.; Matas, P.; Miguez, M.P. Protective effect of melatonin on paraquat-induced cytotoxicity in isolated rat hepatocytes. Hum. Exp. Toxicol. 2005, 24, 475-480.
53. Lee, S.J.; Lee, Y.J.; Park, K.K. The pathogenesis of drug-induced liver injury. Expert Rev. Gastroenterol. Hepatol. 2016, 10, 1175-1185.
54. Taskin, E.; Guven, C.; Sahin, L.; Dursun, N. The cooperative effect of local angiotensin-II in liver with adriamycin hepatotoxicity on mitochondria. Med. Sci. Monit. 2016, 22, 1013-1021.
55. Rapozzi, V.; Comelli, M.; Mavelli, I.; Sentjurc, M.; Schara, M.; Perissin, L.; Giraldi, T. Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, adriamycin. In Vivo 1999, 13, 45-50.
56. Karakilcik, A.Z.; Bitiren, M.; Zerin, M.; Celik, H.; Aksoy, N. Melatonin increased vitamin C and antioxidant enzyme values in the plasma, heart, liver, and kidney of adriamycin-treated rats. Turk. J. Biol. 2015, 39, 925-931.
57. Lee, I.C.; Kim, S.H.; Baek, H.S.; Moon, C.; Bae, C.S.; Kim, S.H.; Yun, W.K.; Nam, K.H.; Kim, H.C.; Kim, J.C. Melatonin improves adriamycin-induced hepatic oxidative damage in rats. Mol. Cell. Toxicol. 2013, 9, 257-265.
58. Jahovic, N.; Cevik, H.; Sehirli, A.O.; Yegen, B.C.; Sener, G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J. Pineal Res. 2003, 34, 282-287.
59. Shokrzadeh, M.; Ahmadi, A.; Naghshvar, F.; Chabra, A.; Jafarinejhad, A. Prophylactic efficacy of melatonin on cyclophosphamide-induced liver toxicity in mice. Biomed Res. Int. 2014, 2014, 470425.
60. Aydin, M.; Oktar, S.; Ozkan, O.V.; Alcin, E.; Ozturk, O.H.; Nacar, A. Letrozole induces hepatotoxicity without causing oxidative stress: The protective effect of melatonin. Gynecol. Endocrinol. 2011, 27, 209-215.
61. Rezzani, R.; Buffoli, B.; Rodella, L.; Stacchiotti, A.; Bianchi, R. Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver. Int. Immunopharmacol. 2005, 5, 1397-1405.
62. Kurus, M.; Esrefoglu, M.; Sogutlu, G.; Atasever, A. Melatonin prevents cyclosporine-induced hepatotoxicity in rats. Med. Princ. Pract. 2009, 18, 407-410.
63. Karabulut, A.B.; Ara, C. Melatonin ameliorates tacrolimus (FK-506)’s induced immunosupressive effect in rat liver. Transplant. Proc. 2009, 41, 1875-1877.
64. Huang, Y.H.; Chi, N.F.; Kuan, Y.C.; Chan, L.; Hu, C.J.; Chiou, H.Y.; Chien, L.N. Efficacy of phenytoin, valproic acid, carbamazepine and new antiepileptic drugs on control of late-onset post-stroke epilepsy in Taiwan. Eur. J. Neurol. 2015, 22, 1459-1468.
65. Eghbal, M.A.; Taziki, S.; Sattari, M.R. Protective role of melatonin and taurine against carbamazepine-induced toxicity in freshly isolated rat hepatocytes. Int. J. Morphol. 2013, 31, 1081-1089.
66. Ramantani, G. Of phenobarbital for neonatal seizures: Response rate and refractoriness predictors. Neuropediatrics 2016, 47, 281-282.
67. Eghbal, M.A.; Taziki, S.; Sattari, M.R. Mechanisms of phenytoin-induced toxicity in freshly isolated rat hepatocytes and the protective effects of taurine and/or melatonin. J. Biochem. Mol. Toxicol. 2014, 28, 111-118.
68. El-Sokkary, G.H. An autoradiographic study of cellular proliferaton, DNA synthesis and cell cycle variability in the rat liver caused by phenobarbital-induced oxidative stress: The protective role of melatonin. Cell Mol. Biol. Lett. 2007, 12, 317-330.
69. Silva, A.F.; Sousa, D.S.; Medeiros, A.M.; Macedo, P.T.; Leao, A.H.; Ribeiro, A.M.; Izidio, G.S.; Silva, R.H. Sex and estrous cycle influence diazepam effects on anxiety and memory: Possible role of progesterone. Prog. Neuro Psychopharmacol. Biol. Psychiatry 2016, 70, 68-76.
70. El-Sokkary, G.H. Melatonin and vitamin C administration ameliorate diazepam-induced oxidative stress and cell proliferation in the liver of rats. Cell Prolif. 2008, 41, 168-176.
71. Khouzam, H.R. A review of trazodone use in psychiatric and medical conditions. Postgrad. Med. 2016, 2016, 1-9.
72. Taziki, S.; Sattari, M.R.; Eghbal, M.A. Mechanisms of trazodone-induced cytotoxicity and the protective effects of melatonin and/or taurine toward freshly isolated rat hepatocytes. J. Biochem. Mol. Toxicol. 2013, 27, 457-462.
73. Saha, K.B.; Bo, L.; Zhao, S.; Xia, J.; Sampson, S.; Zaman, R.U. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 2016, 4, CD010631.
74. Sulaiman, A.A.; Al-Shawi, N.N.; Jwaied, A.H.; Mahmood, D.M.; Hussain, S.A. Protective effect of melatonin against chlorpromazine-induced liver disease in rats. Saudi Med. J. 2006, 27, 1477-1482.
75. Ghanem, C.I.; Perez, M.J.; Manautou, J.E.; Mottino, A.D. Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. Pharmacol. Res. 2016, 109, 119-131.
76. Du, K.; Ramachandran, A.; Jaeschke, H. Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biol. 2016, 10, 148-156.
77. Matsura, T.; Nishida, T.; Togawa, A.; Horie, S.; Kusumoto, C.; Ohata, S.; Nakada, J.; Ishibe, Y.; Yamada, K.; Ohta, Y. Mechanisms of protection by melatonin against acetaminophen-induced liver injury in mice. J. Pineal Res. 2006, 41, 211-219.
78. Liang, Y.L.; Zhang, Z.H.; Liu, X.J.; Liu, X.Q.; Tao, L.; Zhang, Y.F.; Wang, H.; Zhang, C.; Chen, X.; Xu, D.X. Melatonin protects against apoptosis-inducing factor (AIF)-dependent cell death during acetaminophen-induced acute liver failure. PLoS ONE 2012, 7, e51911.
79. Zhou, Y.; Zheng, J.; Li, S.; Zhou, T.; Zhang, P.; Li, H.B. Alcoholic beverage consumption and chronic diseases. Int. J. Environ. Res. Public Health 2016, 13, 522.
80. Wang, F.; Li, Y.; Zhang, Y.J.; Zhou, Y.; Li, S.; Li, H.B. Natural products for the prevention and treatment of hangover and alcohol use disorder. Molecules 2016, 21, 64.
81. Wang, F.; Zhang, Y.J.; Zhou, Y.; Li, Y.; Zhou, T.; Zheng, J.; Zhang, J.J.; Li, S.; Xu, D.P.; Li, H.B. Effects of beverages on alcohol metabolism: Potential health benefits and harmful impacts. Int. J. Mol. Sci. 2016, 17, 354.
82. Zhang, Y.J.; Wang, F.; Zhou, Y.; Li, Y.; Zhou, T.; Zheng, J.; Zhang, J.J.; Li, S.; Xu, D.P.; Li, H.B. Effects of 20 selected fruits on ethanol metabolism: Potential health benefits and harmful impacts. Int. J. Environ. Res. Public Health 2016, 13, 399.
83. Zhang, Y.J.; Zhou, T.; Wang, F.; Zhou, Y.; Li, Y.; Zhang, J.J.; Zheng, J.; Xu, D.P.; Li, H.B. The effects of Syzygium samarangense, Passiflora edulis and Solanum muricatum on alcohol-induced liver injury. Int. J. Mol. Sci. 2016, 17, 1616.
84. Hu, S.L.; Yin, S.; Jiang, X.D.; Huang, D.B.; Shen, G. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur. J. Pharmacol. 2009, 616, 287-292.
85. Mishra, A.; Paul, S.; Swarnakar, S. Downregulation of matrix metalloproteinase-9 by melatonin during prevention of alcohol-induced liver injury in mice. Biochimie 2011, 93, 854-866.
86. Taysi, S.; Koc, M.; Buyukokuroglu, M.E.; Altinkaynak, K.; Sahin, Y.N. Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver. J. Pineal Res. 2003, 34, 173-177.
87. Shirazi, A.; Mihandoost, E.; Ghobadi, G.; Mohseni, M.; Ghazi-Khansari, M. Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver tissue damage. Cell J. 2013, 14, 292-297.
88. Karbownik, M.; Reiter, R.J.; Qi, W.B.; Garcia, J.J.; Tan, D.X.; Manchester, L.C.; Vijayalaxmi. Protective effects of melatonin against oxidation of guanine bases in DNA and decreased microsomal membrane fluidity in rat liver induced by whole body ionizing radiation. Mol. Cell. Biochem. 2000, 211, 137-144.
89. Koc, M.; Taysi, S.; Buyukokuroglu, M.E.; Bakan, N. Melatonin protects rat liver against irradiation-induced oxidative injury. J. Radiat. Res. 2003, 44, 211-215.
90. Djordjevic, B.; Sokolovic, D.; Kocic, G.; Veljkovic, A.; Despotovic, M.; Basic, J.; Jevtovic-Stoimenov, T.; Sokolovic, D.M. The effect of melatonin on the liver of rats exposed to microwave radiation. Bratisl. Med. J. 2015, 116, 96-100.
91. Taghizadieh, M.; Hajipour, B.; Asl, N.A.; Khodadadi, A.; Somi, M.H.; Banei, M. Combination effect of melatonin and dexamethasone on liver ischemia/reperfusion injury. Bratisl. Med. J. 2016, 117, 47-53.
92. Kang, J.W.; Cho, H.I.; Lee, S.M. Melatonin inhibits mTOR-dependent autophagy during liver ischemia/reperfusion. Cell. Physiol. Biochem. 2014, 33, 23-36.
93. Deng, W.S.; Xu, Q.; Liu, Y.; Jiang, C.H.; Zhou, H. Effects of melatonin on liver function and lipid peroxidation in a rat model of hepatic ischemia/reperfusion injury. Exp. Ther. Med. 2016, 11, 1955-1960.
94. Kang, J.W.; Lee, S.M. Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. J. Pineal Res. 2012, 53, 67-76.
95. Bekyarova, G.; Tzaneva, M.; Hristova, M.; Hristov, K. Melatonin protection against burn-induced liver injury. A review. Cent. Eur. J. Med. 2014, 9, 148-158.
96. Bekyarova, G.; Apostolova, M.; Kotzev, I. Melatonin protection against burn-induced hepatic injury by down-regulation of nuclear factor κB activation. Int. J. Immunopathol. Pharmacol. 2012, 25, 591-596.
97. Bekyarova, G.; Bratchkova, Y.; Tancheva, S.; Hristova, M. Effective melatonin protection of burn-induced hepatic disorders in rats. Cent. Eur. J. Med. 2012, 7, 533-538.
98. Bekyarova, G.; Tzaneva, M.; Hristova, M. Melatonin protects against burn-induced hepatic oxidative injury by inducing HO-1 via the Nrf2 pathway. Vet. Med. 2015, 60, 621-628.
99. Nickkholgh, A.; Schneider, H.; Sobirey, M.; Venetz, W.P.; Hinz, U.; Pelzl, L.H.; Gotthardt, D.N.; Cekauskas, A.; Manikas, M.; Mikalauskas, S. et al. The use of high-dose melatonin in liver resection is safe: First clinical experience. J. Pineal Res. 2011, 50, 381-388.
100. Montilla, P.; Cruz, A.; Padillo, F.J.; Tunez, I.; Gascon, F.; Munoz, M.C.; Gomez, M.; Pera, C. Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. J. Pineal Res. 2001, 31, 138-144.
101. Ohta, Y.; Kongo, M.; Kishikawa, T. Melatonin exerts a therapeutic effect on cholestatic liver injury in rats with bile duct ligation. J. Pineal Res. 2003, 34, 119-126.
102. Hsu, J.T.; Kuo, C.J.; Chen, T.H.; Wang, F.; Lin, C.J.; Yeh, T.S.; Hwang, T.L.; Jan, Y.Y. Melatonin prevents hemorrhagic shock-induced liver injury in rats through an Akt-dependent HO-1 pathway. J. Pineal Res. 2012, 53, 410-416.
103. Oner, J.; Ozan, E. Effects of melatonin on liver of rats with experimental hyperthyroid. Acta Vet. Beogr. 2005, 55, 31-39.
104. Martinez-Cruz, F.; Osuna, C.; Guerrero, J.M. Mitochondrial damage induced by fetal hyperphenylalaninemia in the rat brain and liver: Its prevention by melatonin, vitamin E, and vitamin C. Neurosci. Lett. 2006, 392, 1-4.
105. Sener, G.; Balkan, J.; Cevikbas, U.; Keyer-Uysal, M.; Uysal, M. Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL/6J mice. J. Pineal Res. 2004, 36, 212-216.
106. Balkan, J.; Sener, G.; Cevikbas, U.; Keyer-Uysall, M.; Uysall, M. Melatonin improved the disturbances in hepatic prooxidant and antioxidant balance and hepatotoxicity induced by a high cholesterol diet in C57BL/6J mice. Int. J. Vitam. Nutr. Res. 2004, 74, 349-354.
107. Baydas, G.; Ercel, E.; Canatan, H.; Donder, E.; Akyol, A. Effect of melatonin on oxidative status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem. Funct. 2001, 19, 37-41.
108. Gedikli, S.; Gelen, V.; Sengul, E.; Ozkanlar, S.; Gur, C.; Agirbas, O.; Cakmak, F.; Kara, A. Therapeutic effects of melatonin on liver and kidney damages in intensive exercise model of rats. Endocr. Metab. Immune Disord. Drug Targets 2015, 15, 308-314.
109. Wang, H.; Wei, W.; Shen, Y.X.; Dong, C.; Zhang, L.L.; Wang, N.P.; Yue, L.; Xu, S.Y. Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide. World J. Gastroenterol. 2004, 10, 2690-2696.
110. Laothong, U.; Pinlaor, P.; Hiraku, Y.; Boonsiri, P.; Prakobwong, S.; Khoontawad, J.; Pinlaor, S. Protective effect of melatonin against Opisthorchis viverrini-induced oxidative and nitrosative DNA damage and liver injury in hamsters. J. Pineal Res. 2010, 49, 271-282.
111. Tunon, M.J.; Miguel, B.S.; Crespo, I.; Jorquera, F.; Santamaria, E.; Alvarez, M.; Prieto, J.; Gonzalez-Gallego, J. Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J. Pineal Res. 2011, 50, 38-45.
112. San-Miguel, B.; Crespo, I.; Vallejo, D.; Alvarez, M.; Prieto, J.; Gonzalez-Gallego, J.; Tunon, M.J. Melatonin modulates the autophagic response in acute liver failure induced by the rabbit hemorrhagic disease virus. J. Pineal Res. 2014, 56, 313-321.
113. Norris, G.H.; Porter, C.M.; Jiang, C.; Millar, C.L.; Blesso, C.N. Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice. J. Nutr. Biochem. 2017, 40, 36-43.
114. Tiao, M.M.; Huang, L.T.; Chen, C.J.; Sheen, J.M.; Tain, Y.L.; Chen, C.C.; Kuo, H.C.; Huang, Y.H.; Tang, K.S.; Chu, E.W.; Yu, H.R. Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure. BioMed Res. Int. 2014, 2014, 942172.
115. Hermoso, D.A.M.; Shimada, L.B.C.; Gilglioni, E.H.; Constantin, J.; Mito, M.S.; Hermoso, A.P.M.; Salgueiro-Pagadigorria, C.L.; Iwamoto, E.L.I. Melatonin protects female rats against steatosis and liver oxidative stress induced by oestrogen deficiency. Life Sci. 2016, 157, 178-186.
116. Kim, S.J.; Kang, H.S.; Lee, J.H.; Park, J.H.; Jung, C.H.; Bae, J.H.; Oh, B.C.; Song, D.K.; Baek, W.K.; Im, S.S. Melatonin ameliorates ER stress-mediated hepatic steatosis through miR-23a in the liver. Biochem. Biophys. Res. Commun. 2015, 458, 462-469.
117. Pan, M.; Song, Y.L.; Xu, J.M.; Gan, H.Z. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. J. Pineal Res. 2006, 41, 79-84.
118. Stacchiotti, A.; Favero, G.; Lavazza, A.; Golic, I.; Aleksic, M.; Korac, A.; Rodella, L.F.; Rezzani, R. Hepatic macrosteatosis is partially converted to microsteatosis by melatonin supplementation in ob/ob mice non-alcoholic fatty liver disease. PLoS ONE 2016, 11, e0148115.
119. Ferraro, S.M.; Lopez-Ortega, A. Antioxidant activity of melatonin on fatty liver induced by ethionine in mice. Arch. Med. Vet. 2008, 40, 51-57.
120. Celinski, K.; Konurek, P.C.; Slomka, M.; Cichoz-Lach, H.; Brzozowski, T.; Konturek, S.J.; Korolczuk, A. Effects of treatment with melatonin and tryptophan on liver enzymes, parametrs of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease-14 months follow up. J. Physiol. Pharmacol. 2014, 65, 75-82.
121. Shima, T.; Uto, H.; Ueki, K.; Takamura, T.; Kohgo, Y.; Kawata, S.; Yasui, K.; Park, H.; Nakamura, N.; Nakatou, T. et al. Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus. J. Gastroenterol. 2013, 48, 515-525.
122. Agil, A.; Elmahallawy, E.K.; Rodriguez-Ferrer, J.M.; Adem, A.; Bastaki, S.M.; Al-abbadi, I.; Fino Solano, Y.A.; Navarro-Alarcon, M. Melatonin increases intracellular calcium in the liver, muscle, white adipose tissues and pancreas of diabetic obese rats. Food Funct. 2015, 6, 2671-2678.
123. Shieh, J.M.; Wu, H.T.; Cheng, K.C.; Cheng, J.T. Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKC zeta-Akt-GSK3 beta pathway in hepatic cells. J. Pineal. Res. 2009, 47, 339-344.
124. Zavodnik, I.B.; Lapshina, E.A.; Cheshchevik, V.T.; Dremza, I.K.; Kujawa, J.; Zabrodskaya, S.V.; Reiter, R.J. Melatonin and succinate reduce rat liver mitochondrial dysfunction in diabetes. J. Physiol. Pharmacol. 2011, 62, 421-427.
125. Vardi, N.; Iraz, M.; Ozturk, F.; Gul, M.; Ucar, M.; Cetin, A.; Nalcaci, N.; Otlu, A. Improving effects of melatonin against on the histologic alterations of rat liver in diabetes. Turk. Klin. Tip Bilim. Derg. 2007, 27, 641-648.
126. Elbe, H.; Esrefoglu, M.; Vardi, N.; Taslidere, E.; Ozerol, E.; Tanbek, K. Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats. Hum. Exp. Toxicol. 2015, 34, 859-868.
127. Guven, A.; Yavuz, O.; Cam, M.; Ercan, F.; Bukan, N.; Comunoglu, C.; Gokce, F. Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem. 2006, 108, 85-93.
128. Korkmaz, G.G.; Uzun, H.; Cakatay, U.; Aydin, S. Melatonin ameliorates oxidative damage in hyperglycemia-induced liver injury. Clin. Investig. Med. 2012, 35, 370-377.
129. Agarkov, A.A.; Popova, T.N.; Matasova, L.V. Effects of melatonin on the activity of the glutathione antioxidant system and various NADPH-generating enzymes in the liver and blood of rats with type 2 diabetes mellitus. Pharm. Chem. J. 2011, 45, 385-388.
130. Allagui, M.S.; Feriani, A.; Bouoni, Z.; Alimi, H.; Murat, J.C.; El Feki, A. Protective effects of vitamins (C and E) and melatonin co-administration on hematological and hepatic functions and oxidative stress in alloxan-induced diabetic rats. J. Physiol. Biochem. 2014, 70, 713-723.
131. Cheshchevik, V.T.; Dremza, I.K.; Lapshina, E.A.; Zabrodskaya, S.V.; Kujawa, J.; Zavodnik, I.B. Corrections by melatonin of liver mitochondrial disorders under diabetes and acute intoxication in rats. Cell Biochem. Funct. 2011, 29, 481-488.
132. Liu, Y.Q.; Dai, J.; Hu, K.; Cai, L.; Lin, L.; Ge, P.; Zhang, L. Metformin alleviates acetaminophen-induced toxic hepatitis. Genom. Appl. Biol. 2016, 35, 1633-1637.
133. Kurtgoz, P.O.; Tunay, H.; Kurban, F.; Kurtgoz, S.; Demir, K.; Acarturk, G. Toxic hepatitis associated with amoxicillin-clavulanic acid in a chronic viral hepatitis B patient: A case report. Med. J. Bakirkoy 2016, 12, 92-95.
134. Thomas, F.V.; Mingo, A.T.; Mantes, D.R.; Uribe, S.O. Albendazole-induced toxic hepatitis. Gastroenterol. Hepatol. 2015, 38, 436-438.
135. Castiella, A.; Iglesias, U.; Zapata, E.; Zubiaurre, L.; Iribarren, A. Toxic hepatocellular hepatitis due to labetalol. Gastroenterol. Hepatol. 2015, 38, 326-327.
136. Couturier, F.J.; Colemont, L.J.; Fierens, H.; Verhoeven, V.M. Toxic hepatitis due to a food supplement: “Natural” is no synonym for “harmless”. Clin. Res. Hepatol. Gastroenterol. 2016, 40, 38-43.
137. Pashkov, A.N.; Popov, S.S.; Semenikhina, A.V.; Rakhmanova, T.I. Glutathione system and activity of NADPH-generating enzymes in the liver of intact rats and animals with toxic hepatitis receiving melatonin. Bull. Exp. Biol. Med. 2005, 139, 565-568.
138. Laliena, A.; San Miguel, B.; Crespo, I.; Alvarez, M.; Gonzalez-Gallego, J.; Tunon, M.J. Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. J. Pineal Res. 2012, 53, 270-278.
139. Tunon, M.J.; San-Miguel, B.; Crespo, I.; Laliena, A.; Vallejo, D.; Alvarez, M.; Prieto, J.; Gonzalez-Gallego, J. Melatonin treatment reduces endoplasmic reticulum stress and modulates the unfolded protein response in rabbits with lethal fulminant hepatitis of viral origin. J. Pineal Res. 2013, 55, 221-228.
140. Gonciarz, M.; Gonciarz, Z.; Bielanski, W.; Mularczyk, A.; Konturek, P.C.; Brzozowski, T.; Konturek, S.J. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: Effect on plasma levels of liver enzymes, lipids, and melatonin. J. Physiol. Pharmacol. 2010, 61, 705-710.
141. Gonciarz, M.; Gonciarz, Z.; Bielanski, W.; Mularczyk, A.; Konturek, P.C.; Brzozowski, T.; Konturek, S.J. The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: A pilot study. J. Physiol. Pharmacol. 2012, 63, 35-40.
142. Wang, P.; Koyama, Y.; Liu, X.; Xu, J.; Ma, H.Y.; Liang, S.; Kim, I.H.; Brenner, D.A.; Kisseleva, T. Promising therapy candidates for liver fibrosis. Front. Physiol. 2016, 7, 47.
143. Crespo, I.; San-Miguel, B.; Fernandez, A.; De Urbina, J.O.; Gonzalez-Gallego, J.; Tunon, M.J. Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice. Transl. Res. 2015, 165, 346-357.
144. Shajari, S.; Laliena, A.; Heegsma, J.; Tunon, M.J.; Moshage, H.; Faber, K.N. Melatonin suppresses activation of hepatic stellate cells through ROR α-mediated inhibition of 5-lipoxygenase. J. Pineal Res. 2015, 59, 391-401.
145. Choi, H.S.; Kang, J.W.; Lee, S.M. Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis. Transl. Res. 2015, 166, 292-303.
146. Mortezaee, K.; Sabbaghziarani, F.; Omidi, A.; Dehpour, A.R.; Omidi, N.; Ghasemi, S.; Pasbakhsh, P.; Kashani, I.R. Therapeutic value of melatonin post-treatment on CCl4-induced fibrotic rat liver. Can. J. Physiol. Pharmacol. 2016, 94, 119-130.
147. Wang, H.; Wei, W.; Wang, N.P.; Gui, S.Y.; Wu, L.; Sun, W.Y. Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Life Sci. 2005, 77, 1902-1915.
148. Kang, J.W.; Hong, J.M.; Lee, S.M. Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. J. Pineal Res. 2016, 60, 383-393.
149. Hong, R.T.; Xu, J.M.; Mei, Q. Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. World J. Gastroentero. 2009, 15, 1452-1458.
150. Cho, Y.A.; Noh, K.; Jue, S.S.; Lee, S.Y.; Kim, E.C. Melatonin promotes hepatic differentiation of human dental pulp stem cells: Clinical implications for the prevention of liver fibrosis. J. Pineal Res. 2015, 58, 127-135.
151. Tahan, G.; Akin, H.; Aydogan, F.; Ramadan, S.S.; Yapicier, O.; Tarcin, O.; Uzun, H.; Tahan, V.; Zengin, K. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats. Can. J. Surg. 2010, 53, 313-318.
152. Czechowska, G.; Celinski, K.; Korolczuk, A.; Wojcicka, G.; Dudka, J.; Bojarska, A.; Reiter, R.J. Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats. J Physiol. Pharmacol. 2015, 66, 567-579.
153. Tahan, V.; Ozaras, R.; Canbakan, B.; Uzun, H.; Aydin, S.; Yildirim, B.; Aytekin, H.; Ozbay, G.; Mert, A.; Senturk, H. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J. Pineal Res. 2004, 37, 78-84.
154. Cruz, A.; Padillo, F.J.; Torres, E.; Navarrete, C.M.; Munoz-Castaneda, J.R.; Caballero, F.J.; Briceno, J.; Marchal, T.; Tunez, I.; Montilla, P. et al. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J. Pineal Res. 2005, 39, 143-150.
155. Chojnacki, C.; Walecka-Kapica, E.; Klupinska, G.; Wachowska-Kelly, P.; Zylinska, K.; Winczyk, K.; Chojnacki, J. Serotonin and melatonin secretion and metabolism in patients with liver cirrhosis. Pol. Arch. Med. Wewn. 2012, 122, 392-397.
156. Cunnane, S.C.; Manku, M.S.; Horrobin, D.F. The pineal and regulation of fibrosis: Pinealectomy as a model of primary biliary cirrhosis: Roles of melatonin and prostaglandins in fibrosis and regulation of T lymphocytes. Med. Hypotheses 1979, 5, 403-414.
157. Colares, J.R.; Schemitt, E.G.; Hartmann, R.M.; Licks, F.; Soares, M.D.; Dal Bosco, A.; Marroni, N.P. Antioxidant and anti-inflammatory action of melatonin in an experimental model of secondary biliary cirrhosis induced by bile duct ligation. World J. Gastroenterol. 2016, 22, 8918-8928.
158. Celinski, K.; Konturek, P.C.; Slomka, M.; Cichoz-Lach, H.; Gonciarz, M.; Bielanski, W.; Reiter, R.J.; Konturek, S.J. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan. J. Pineal Res. 2009, 46, 408-414.
159. Zhou, Y.; Zheng, J.; Li, Y.; Xu, D.P.; Li, S.; Chen, Y.M.; Li, H.B. Natural polyphenols for prevention and treatment of cancer. Nutrients 2016, 8, 515.
160. Li, F.; Li, S.; Li, H.B.; Deng, G.F.; Ling, W.H.; Xu, X.R. Antiproliferative activities of tea and herbal infusions. Food Funct. 2013, 4, 530-538.
161. Carbajo-Pescador, S.; Martin-Renedo, J.; Garcia-Palomo, A.; Tunon, M.J.; Mauriz, J.L.; Gonzalez-Gallego, J. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells. J. Pineal Res. 2009, 47, 330-338.
162. Zhou, Y.; Li, Y.; Zhou, T.; Zheng, J.; Li, S.; Li, H.B. Dietary natural products for prevention and treatment of liver cancer. Nutrients 2016, 8, 156.
163. Moreira, A.J.; Ordonez, R.; Cerski, C.T.; Picada, J.N.; Garcia-Palomo, A.; Marroni, N.P.; Mauriz, J.L.; Gonzalez-Gallego, J. Melatonin activates endoplasmic reticulum stress and apoptosis in rats with diethylnitrosamine-induced hepatocarcinogenesis. PLoS ONE 2015, 10, e0144517.
164. Zheng, J.; Zhou, Y.; Li, Y.; Xu, D.P.; Li, S.; Li, H.B. Spices for prevention and treatment of cancers. Nutrients 2016, 8, 495.
165. Li, F.; Li, S.; Li, H.B.; Deng, G.F.; Ling, W.H.; Wu, S.; Xu, X.R.; Chen, F. Antiproliferative activity of peels, pulps and seeds of 61 fruits. J. Funct. Foods 2013, 5, 1298-1309.
166. Kimball, S.R.; Abbas, A.; Jefferson, L.S. Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras. J. Pineal Res. 2008, 44, 379-386.
167. Nishimura, J.; Saegusa, Y.; Dewa, Y.; Jin, M.; Kawai, M.; Kemmochi, S.; Harada, T.; Hayashi, S.; Shibutani, M.; Mitsumori, K. Antioxidant enzymatically modified isoquercitrin or melatonin supplementation reduces oxidative stress-mediated hepatocellular tumor promotion of oxfendazole in rats. Arch. Toxicol. 2010, 84, 143-153.
168. Verma, D.; Hashim, O.H.; Jayapalan, J.J.; Subramanian, P. Effect of melatonin on antioxidant status and circadian activity rhythm during hepatocarcinogenesis in mice. J. Canc. Res. Ther. 2014, 10, 1040-1044.
169. Dakshayani, K.B.; Subramanian, R.; Essa, M.M. Effect of melatonin on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats with reference to biochemical circadian rhythms. Toxicol. Mech. Methods 2007, 17, 67-75.
170. Subramanian, P.; Dakshayani, K.B.; Pandi-Perumal, S.R.; Trakht, I.; Cardinali, D.P. 24-hour rhythms in oxidative stress during hepatocarcinogenesis in rats: Effect of melatonin or α-ketoglutarate. Redox Rep. 2008, 13, 78-86.
171. Carbajo-Pescador, S.; Garcia-Palomo, A.; Martin-Renedo, J.; Piva, M.; Gonzalez-Gallego, J.; Mauriz, J.L. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: Role of the MT1 receptor. J. Pineal Res. 2011, 51, 463-471.
172. Hermann, R.; Podhajsky, S.; Jungnickel, S.; Lerchl, A. Potentiation of antiproliferative effects of tamoxifen and ethanol on mouse hepatoma cells by melatonin: Possible involvement of mitogen-activated protein kinase and induction of apoptosis. J. Pineal Res. 2002, 33, 8-13.
173. Cid, M.A.; Ubeda, A.; Hernandez-Bule, M.L.; Martinez, M.A.; Trillo, M.A. Antagonistic effects of a 50 Hz magnetic field and melatonin in the proliferation and differentiation of hepatocarcinoma cells. Cell. Physiol. Biochem. 2012, 30, 1502-1516.
174. Fan, L.L.; Sun, G.P.; Ma, T.; Zhong, F.; Wei, W. Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting Survivin and XIAP. J. Pineal Res. 2013, 55, 174-183.
175. Martin-Renedo, J.; Mauriz, J.L.; Jorquera, F.; Ruiz-Andres, O.; Gonzalez, P.; Gonzalez-Gallego, J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J. Pineal Res. 2008, 45, 532-540.
176. Fan, L.L.; Sun, G.P.; Wei, W.; Wang, Z.G.; Ge, L.; Fu, W.Z.; Wang, H. Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. World J. Gastroenterol. 2010, 16, 1473-1481.
177. Fan, L.L.; Sun, G.P.; Ma, T.; Zhong, F.; Lei, Y.; Li, X.Q.; Wei, W. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing Survivin. J. Pineal Res. 2013, 55, 184-194.
178. Liu, C.; Jia, Z.L.; Zhang, X.; Hou, J.C.; Wang, L.; Hao, S.L.; Ruan, X.J.; Yu, Z.H.; Zheng, Y.Q. Involvement of melatonin in autophagy-mediated mouse hepatoma H22 cell survival. Int. Immunopharmacol. 2012, 12, 394-401.
179. Ordonez, R.; Fernandez, A.; Prieto-Dominguez, N.; Martinez, L.; Garcia-Ruiz, C.; Fernandez-Checa, J.C.; Mauriz, J.L.; Gonzalez-Gallego, J. Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells. J. Pineal Res. 2015, 59, 178-189.
180. Ordonez, R.; Carbajo-Pescador, S.; Prieto-Dominguez, N.; Garcia-Palomo, A.; Gonzalez-Gallego, J.; Mauriz, J.L. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. J. Pineal Res. 2014, 56, 20-30.
181. Lin, Z.Y.; Chuang, W.L. Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Biomed. Pharmacother. 2010, 64, 659-662.
182. Carbajo-Pescador, S.; Ordonez, R.; Benet, M.; Jover, R.; Garcia-Palomo, A.; Mauriz, J.L.; Gonzalez-Gallego, J. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br. J. Cancer 2013, 109, 83-91.